Sarepta Therapeutics (SRPT) EPS (Basic) (2010 - 2026)
Sarepta Therapeutics (SRPT) recorded quarterly EPS (Basic) of $3.15 in Q1 2026, up 180.15% quarter-over-quarter from -$3.93 in Q4 2025, and up 168.48% on a YoY basis from $1.17 in Q1 2025.
Sarepta Therapeutics (SRPT) EPS (Basic) (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' EPS (Basic) history runs 17 years deep, the most recent figure standing at $3.15 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 168.48% year-over-year to $3.15; the TTM figure through Mar 2026 stood at $0.73 (up 128.85% YoY), while the FY2025 annual figure was -$7.13, down 388.66% from the prior year.
- EPS (Basic) was $3.15 for Q1 2026 at Sarepta Therapeutics, up from -$3.93 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $3.15 in Q1 2026 to a low of -$5.86 in Q1 2023.
- Historically, EPS (Basic) has averaged -$0.9 across 5 years, with a median of -$0.46 in 2023.
- Biggest YoY gain for EPS (Basic) was 2771.43% in 2025; the steepest drop was 1310.53% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$1.24 in 2022, then soared by 161.29% to $0.76 in 2023, then jumped by 117.11% to $1.65 in 2024, then sank by 338.18% to -$3.93 in 2025, then surged by 180.15% to $3.15 in 2026.
- The last three EPS (Basic) figures came in at $3.15 (Q1 2026), -$3.93 (Q4 2025), and -$0.5 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Sarepta Therapeutics | 1.84 Bn | 1.16 Bn | 291.52 Mn | 3.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.15 |
| Dec 31, 2025 | -3.93 |
| Sep 30, 2025 | -0.50 |
| Jun 30, 2025 | 2.01 |
| Mar 31, 2025 | -4.60 |
| Dec 31, 2024 | 1.65 |
| Sep 30, 2024 | 0.35 |
| Jun 30, 2024 | 0.07 |
| Mar 31, 2024 | 0.38 |
| Dec 31, 2023 | 0.76 |
| Sep 30, 2023 | -0.46 |
| Jun 30, 2023 | -0.27 |
| Mar 31, 2023 | -5.86 |
| Dec 31, 2022 | -1.24 |
| Sep 30, 2022 | -2.94 |
| Jun 30, 2022 | -2.65 |
| Mar 31, 2022 | -1.20 |
| Dec 31, 2021 | -1.43 |
| Sep 30, 2021 | -0.60 |
| Jun 30, 2021 | -1.02 |